Microbiology
Showing page 200 of 255 pages of list content
-
Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2
This article's authors -
Oligonucleotide capture sequencing of the SARS-CoV-2 genome and subgenomic fragments from COVID-19 individuals
This article's authors -
JIB-04 has broad-spectrum antiviral activity and inhibits SARS-CoV-2 replication and coronavirus pathogenesis
This article's authors -
A simplified cell-based assay to identify coronavirus 3CL protease inhibitors
This article's authors -
A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
This article's authors -
SARS-CoV-2 spike D614G variant exhibits highly efficient replication and transmission in hamsters
This article's authors -
Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay
This article's authors -
SARS-CoV-2 viral budding and entry can be modeled using virus-like particles
This article's authors -
The new generation hDHODH inhibitor MEDS433 hinders the in vitro replication of SARS-CoV-2
This article's authors -
The combination of Bromelain and Acetylcysteine (BromAc) synergistically inactivates SARS-CoV-2
This article's authors